Complex Made Simple

Julphar to start producing insulin in December

The chief executive of Gulf Pharmaceutical Industries (Julphar) has announced that the company will start producing insulin in December at a total cost of Dhs500m, Gulf News has reported. CEO Dr Ayman Sahli has added that the Ras Al Khaimah-based company is planning to export the locally-made insulin to about 40 countries in the GCC, Middle East, Europe and South Asia as of 2012.